Evonik stock slips as H1 revenue and guidance reset bite
Published on 08/26/2026 at 21:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evonik Industries AG stock (DE000EVNK013) trades against a 52-week low nearby after half-year 2026 revenue of EUR 300.1 million and a full-year revenue guide of EUR 570 million to EUR 610 million reshaped the earnings picture. The latest quoted view puts the shares at EUR 18.51, with market value listed at EUR 8.76 billion as of August 26, 2026.
Half-year numbers reset the frame
In the first half of 2026, revenue fell 19.2 percent year over year to EUR 300.1 million, while adjusted EBITDA dropped to a loss of EUR 42.7 million from a negative EUR 1.9 million a year earlier. That gap is the central comparison for investors because it shows that profitability weakened faster than sales.
Management now guides for 2026 revenue between EUR 570 million and EUR 610 million and adjusted EBITDA between a loss of EUR 70 million and a loss of EUR 105 million. The midpoint of the revenue range, EUR 590 million, would still leave the second half carrying slightly more than EUR 289 million in sales if the target is met.
Trading still looks compressed
The market snapshot gives the stock little room for error. At EUR 18.51, the shares sit far below a market cap of EUR 8.76 billion and close to a session range that has been marked by subdued trading in late August.
A separate market view showed the stock at EUR 18.67 on August 25, 2026, with the implied five-year comparison showing a 35.33 percent loss for an investment made five years earlier. That historical frame matters because it shows how far the equity has already re-rated before the latest profit warning fully landed.
What still drives the story
The product side remains rooted in specialties such as additives, coatings, and consumer-oriented chemistry, where pricing power and volume recovery matter more than headline growth. For Evonik, the key question is whether the second half can narrow the gap between the EUR 300.1 million first-half base and the full-year guidance range.
As of August 26, 2026, the stock is priced at EUR 18.51, with market cap listed at EUR 8.76 billion and a 52-week comparison that points to a much weaker equity backdrop than a year ago.
Fact box
Company: Evonik Industries AG
ISIN: DE000EVNK013
Ticker: EVK
Exchange: Xetra
Price (as of August 26, 2026): EUR 18.51
Market cap: EUR 8.76 billion
Sector / Industry: Materials / Specialty Chemicals
Index membership: MDAX
